Chlamydia Trachomatis antibody (Biotin)

Catalog No. ABIN112697

The Goat Polyclonal anti-Chlamydia Trachomatis antibody has been validated for WB and EIA. It is suitable to detect Chlamydia Trachomatis in samples from Chlamydia trachomatis.

Quick Overview for Chlamydia Trachomatis antibody (Biotin) (ABIN112697)

Target: Chlamydia Trachomatis

Reactivity: Chlamydia trachomatis

Host: Goat

Clonality: Polyclonal

Conjugate: This Chlamydia Trachomatis antibody is conjugated to Biotin

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Product Details anti-Chlamydia Trachomatis Antibody (Biotin)

Immunogen: Purified MOMP from strain L2

Application Details

Application Notes: Suitable for use with avidin and streptavidin amplification systems for fluorescencemicroscopy.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 4-5 mg/mL (OD280 nm, E0.1% = 1.4)

Buffer: 0.01 M PBS, pH 7.2 containing 0.09 % sodium azide as preservative. Without stabilizer.

Preservative: Sodium azide

Precaution of Use: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details for Chlamydia Trachomatis

Target: Chlamydia Trachomatis

Target Type: Bacteria

Background: Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5 % to 10 %. Chlamydia is one of the leading causes of blindness in underdeveloped countries.